What does CUSIP 55279B202 represent in this 13F holders report?

CUSIP 55279B202 is the security identifier for MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value used to aggregate holder disclosures.

How many institutions held MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value in Q1 2022?

85 institutional investors reported MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value for Q1 2022. Use the holders table for investor-level position and value details.

MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP)

CUSIP: 55279B202

Q1 2022 13F Holders as of 31 Mar 2022

Security type / class: Equity / Common Stock, $0.00000002 par value
Total 13F shares: 56,055,550
Total 13F value: $33,769,440
Share change: -32,768,050
Put/Call ratio: 19%
SEC-reported price per share: $0.60
Number of holders: 85
Value change: -$85,348,603
Number of buys: 48
Number of sells: 55
Shares outstanding: 29,545,622

Security key

55279B202

Report period

Q1 2022

Institutions

Top holders

MEIP full security history Ownership snapshot Full 13F holder table Lite Strategy, Inc. SEC filings Lite Strategy, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

MPM BioImpact LLC

Disclosed value leader

MPM BioImpact LLC

Comparable rows

15/15

Latest evidence

31 Dec 2021

13F Lead comparable stake: 42% Showing 1-6 of 15 holder rows.

Quick read

MPM BioImpact LLC leads the comparable SEC ownership view at 42%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MPM BioImpact LLC's linked filing trail.

Comparable ownership Top 5

MPM BioImpact LLC 42%

First Light Asset Management, LLC 38%

WASATCH ADVISORS LP 32%

NEA Management Company, LLC 29%

BlackRock Finance, Inc. 23%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
MPM BioImpact LLC	13F Company 13F	42%	$32,977,000 12,350,971 shares	—	31 Dec 2021
First Light Asset Management, LLC	13F Company 13F	38%	$29,951,000 11,217,426 shares	—	31 Dec 2021
WASATCH ADVISORS LP	13F Company 13F	32%	$24,944,000 9,342,310 shares	—	31 Dec 2021
NEA Management Company, LLC	13F Company 13F	29%	$22,783,000 8,533,072 shares	—	31 Dec 2021
BlackRock Finance, Inc.	13F Company 13F	23%	$17,861,000 6,689,871 shares	—	31 Dec 2021
VANGUARD GROUP INC	13F Company 13F	20%	$15,405,000 5,769,739 shares	—	31 Dec 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

56,055,550

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q1 2022 value	Q1 2022 value	Value change	Value Chg %